Home › Immunoglobulin Light-chain Amyloidosis › New York
Immunoglobulin Light-chain Amyloidosis clinical trials in New York
4 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in New York.
Cities in New York
Teclistamab-Daratumumab in AL Amyloidosis
- Columbia University Irving Medical Center, New York
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 13, 2026 · NCT07110844A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, New York
- Research Site, New York
- Research Site, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.